In conjunction with other markers, the CK-18 fragment level was proposed as a biomarker for fibrotic NASH diagnosis, for which quantification provides the most used biomarker of steatohepatitis, despite its low accuracy [20,38,70]. Here, KRT18 is linked to metabolic dysfunction-associated steatohepatitis.